The WHO Clinical Staging System for HIV/AIDS allows physicians in resource-limited settings to make clinical decisions based on patient clinical features instead of laboratory tests.
Clinical decision making calls for use of both explicit and tacit knowledge despite evidence-based medicine's assumption that explicit information is sufficient.
Does a surgeon’s complication rate in a randomized controlled trial constitute a “significant new finding” that must be reported to patients during the consent process?